X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Divis Laboratories with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs STERLING BIOTECH - Comparison Results

DIVIS LABORATORIES    Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES STERLING BIOTECH DIVIS LABORATORIES/
STERLING BIOTECH
 
P/E (TTM) x 34.8 -0.7 - View Chart
P/BV x 5.6 0.0 20,010.6% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 DIVIS LABORATORIES   STERLING BIOTECH
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-17
STERLING BIOTECH
Dec-13
DIVIS LABORATORIES/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,22211 11,638.1%   
Low Rs7843 23,058.8%   
Sales per share (Unadj.) Rs153.126.8 571.1%  
Earnings per share (Unadj.) Rs39.9-15.0 -267.1%  
Cash flow per share (Unadj.) Rs44.6-5.5 -816.3%  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs201.854.9 367.7%  
Shares outstanding (eoy) m265.47267.87 99.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.60.3 2,526.9%   
Avg P/E ratio x25.1-0.5 -5,403.7%  
P/CF ratio (eoy) x22.5-1.3 -1,768.0%  
Price / Book Value ratio x5.00.1 3,924.7%  
Dividend payout %25.00-   
Avg Mkt Cap Rs m266,2661,862 14,302.3%   
No. of employees `0009.71.4 719.0%   
Total wages/salary Rs m4,687547 857.2%   
Avg. sales/employee Rs Th4,175.05,303.3 78.7%   
Avg. wages/employee Rs Th481.5403.8 119.2%   
Avg. net profit/employee Rs Th1,089.3-2,959.0 -36.8%   
INCOME DATA
Net Sales Rs m40,6437,181 566.0%  
Other income Rs m74943 1,758.0%   
Total revenues Rs m41,3927,223 573.0%   
Gross profit Rs m14,460947 1,527.1%  
Depreciation Rs m1,2332,543 48.5%   
Interest Rs m234,377 0.5%   
Profit before tax Rs m13,953-5,931 -235.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,349-1,924 -174.0%   
Profit after tax Rs m10,604-4,007 -264.7%  
Gross profit margin %35.613.2 269.8%  
Effective tax rate %24.032.4 74.0%   
Net profit margin %26.1-55.8 -46.8%  
BALANCE SHEET DATA
Current assets Rs m40,10514,335 279.8%   
Current liabilities Rs m6,59549,809 13.2%   
Net working cap to sales %82.5-494.0 -16.7%  
Current ratio x6.10.3 2,113.2%  
Inventory Days Days119403 29.4%  
Debtors Days Days81171 47.3%  
Net fixed assets Rs m19,99555,432 36.1%   
Share capital Rs m531268 198.2%   
"Free" reserves Rs m53,04313,935 380.6%   
Net worth Rs m53,57414,701 364.4%   
Long term debt Rs m09,478 0.0%   
Total assets Rs m61,58573,988 83.2%  
Interest coverage x618.4-0.4 -174,218.3%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.70.1 680.0%   
Return on assets %17.30.5 3,445.0%  
Return on equity %19.8-27.3 -72.6%  
Return on capital %26.1-6.4 -406.0%  
Exports to sales %025.9 0.0%   
Imports to sales %25.20.2 14,857.4%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs m10,25912 84,094.2%   
Fx inflow Rs m35,3841,860 1,902.6%   
Fx outflow Rs m10,39925 41,778.5%   
Net fx Rs m24,9851,835 1,361.7%   
CASH FLOW
From Operations Rs m11,4931,719 668.7%  
From Investments Rs m-11,372-3,148 361.2%  
From Financial Activity Rs m-931,426 -6.5%  
Net Cashflow Rs m28-3 -835.3%  

Share Holding

Indian Promoters % 52.0 33.9 153.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.8 0.0 -  
FIIs % 19.0 9.9 191.9%  
ADR/GDR % 0.0 16.9 -  
Free float % 17.2 39.3 43.8%  
Shareholders   31,796 21,482 148.0%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA  PFIZER  ALKEM LABORATORIES  GLENMARK PHARMA  VENUS REMEDIES  

Compare DIVIS LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade in Red, Petrol Prices at All-time Highs, and Top Stocks in Action(Pre-Open)

On Monday, share markets in India opened on a negative note and ended the day in red after a dull day of trading.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


May 21, 2018 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS